-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
-
-
-
-
-
-
-
UroGen Announces $120 Million Private Placement of Ordinary Shares
-
-
-
-
-
-
-
UroGen To Host Investor Day on September 24, 2019 Spotlighting Clinical Development Updates and UGN-101 Launch Readiness
-
-
21,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

